Low Molecular Weight Heparin in the Treatment of Venous and Arterial Thromboses in the Premature Infant

Abstract

Higher doses of LMWH are required in the preterm infant as compared with the healthy term neonate. Once therapeutic levels are achieved, continued regular monitoring and dose adjustments are required to maintain anticoagulation in therapeutic range.